Evidence map›Paper›PMID 38419563›Full record

ArticleThoracic cancer2024

Enhancing precision in lung tumor ablation through innovations in CT-guided technique and angle control.

Wei-Te Hung, Stella Chin-Shaw Tsai, Tzu-Chin Wu, Hsien-Tang Tu, Huan-Cheng Lin, Chun-Lin Su, Yu-Chieh Wu, Li-Cheng Lin, Frank Cheau-Feng Lin

Open access · goldAbstract read
In one paragraph

Article in Thoracic cancer, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Wei-Te HungSchool of Medicine, Chung Shan Medical University, Taichung, Taiwan.
Stella Chin-Shaw TsaiSuperintendent Office, Taichung MetroHarbor Hospital, Taichung, Taiwan.
Tzu-Chin WuDepartment of Thoracic Medicine, Chung Shan Medical University Hospital, Taichung, Taiwan.
Hsien-Tang TuSchool of Medicine, Chung Shan Medical University, Taichung, Taiwan.
Huan-Cheng LinSchool of Medicine, Chung Shan Medical University, Taichung, Taiwan.
Chun-Lin SuSchool of Medicine, Chung Shan Medical University, Taichung, Taiwan.
Yu-Chieh WuSchool of Medicine, Chung Shan Medical University, Taichung, Taiwan.
Li-Cheng LinSchool of Medicine, Chung Shan Medical University, Taichung, Taiwan.
Frank Cheau-Feng LinSchool of Medicine, Chung Shan Medical University, Taichung, Taiwan.ORCID 0000-0001-5301-2345
Chung Shan Medical University · TWChung Shan Medical University Hospital · TWNational Chung Hsing University · TW

Funding

Tungs' Taichung MetroHarbor Hospital TTMHH-R1120009
6 · The paper itself

Abstract

backgroundThis retrospective study aimed to evaluate the precision and safety outcomes of image-guided lung percutaneous thermal ablation (LPTA) methods, focusing on radiofrequency ablation (RFA) and microwave ablation (MWA). The study utilized an innovative angle reference guide to facilitate these techniques in the treatment of lung tumors.

methodsThis study included individuals undergoing LPTA with the assistance of laser angle guide assembly (LAGA) at our hospital between April 2011 and March 2021. We analyzed patient demographics, tumor characteristics, procedure details, and complications. Logistic regressions were employed to assess risk factors associated with complications.

resultsA total of 202 patients underwent ablation for 375 lung tumors across 275 sessions involving 495 ablations. Most procedures used RFA, especially in the right upper lobe, and the majority of ablations were performed in the prone position (49.7%). Target lesions were at a median depth of 39.3 mm from the pleura surface, and remarkably, 91.9% required only a single puncture. Complications occurred in 31.0% of ablations, with pneumothorax being the most prevalent (18.3%), followed by pain (12.5%), sweating (6.5%), fever (5.0%), cough (4.8%), hemothorax (1.6%), hemoptysis (1.2%), pleural effusion (2.0%), skin burn (0.6%), and air emboli (0.2%). The median procedure time was 21 min. Notably, smoking/chronic obstructive pulmonary disease emerged as a significant risk factor for complications.

conclusionThe LAGA-assisted LPTA enhanced safety by improving accuracy and reducing risks. Overall, this investigation contributes to the ongoing efforts to refine and improve the clinical application of these thermal ablation techniques in the treatment of lung tumors.

Indexed as

Catheter AblationHyperthermia, InducedLung NeoplasmsHumansLungRetrospective StudiesTomography, X-Ray ComputedTreatment Outcomeangle reference guideimage‐guidedlung cancermicrowave ablationsradiofrequency ablation

Identifiers

PMID38419563
PMCPMC11016418
OpenAlexW4392287053

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.